Evidence map›Paper›PMID 39457626›Full record

ArticleBiomedicines2024

From Gut to Blood: Redistribution of Zonulin in People Living with HIV.

Max Augustin, Carola Horn, Meryem Seda Ercanoglu, Vincent Bondet, Ute Sandaradura de Silva, Isabelle Suarez, Seung-Hun Chon, Dirk Nierhoff, Alexander Zoufaly, Christoph Wenisch and 6 more

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Max AugustinDepartment I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0002-2300-9337
Carola HornDepartment I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Meryem Seda ErcanogluInstitute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Vincent BondetTranslational Immunology Unit, Institut Pasteur, Université Paris-Cité, 75015 Paris, France.ORCID 0000-0002-6534-0984
Ute Sandaradura de SilvaDepartment I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Isabelle SuarezDepartment I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Seung-Hun ChonDepartment of General, Visceral Surgery and Surgical Oncology, University Hospital Cologne, 50937 Cologne, Germany.ORCID 0000-0002-8923-6428
Dirk NierhoffDepartment of Gastroenterology and Hepatology, University Hospital of Cologne, 50937 Cologne, Germany.ORCID 0000-0001-7297-2675
Alexander ZoufalyDepartment IV of Internal Medicine, Klinik Favoriten, Vienna Healthcare Group, 1100 Vienna, Austria.
Christoph WenischDepartment IV of Internal Medicine, Klinik Favoriten, Vienna Healthcare Group, 1100 Vienna, Austria.
Elena KnopsInstitute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0001-7398-3026
Eva HegerInstitute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Florian KleinInstitute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0003-1376-1792
Darragh DuffyTranslational Immunology Unit, Institut Pasteur, Université Paris-Cité, 75015 Paris, France.ORCID 0000-0002-8875-2308
Michaela Müller-TrutwinHIV, Inflammation and Persistence Unit, Institut Pasteur, Université Paris-Cité, 75015 Paris, France.ORCID 0000-0002-3854-2396
Clara LehmannDepartment I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.

Funding

German Center for Infection Research DZIF TTU HIV 04.820
6 · The paper itself

Abstract

backgroundGastrointestinal mucosal damage due to human immunodeficiency virus (HIV) infection leads to microbial translocation and immune activation, contributing to the development of non-infectious comorbidities (NICM) in people living with HIV (PLWH). Additionally, persistent proviral HIV-1 in the gut-associated lymphatic tissue (GALT) can trigger immunological changes in the epithelial environment, impacting the mucosal barrier. However, the role of zonulin, a modulator of epithelial tight junctions in GALT during HIV infection, remains poorly understood.

methodsWe measured zonulin in serum and intestinal tissue sections from five treatment-naive (HIV

resultsUpon HIV infection, TI was found to harbor more HIV DNA than PB. Circulating zonulin levels were highest in HIV

conclusionsThe findings of this study indicate a shift in zonulin levels from the gut to the bloodstream in response to HIV infection. Furthermore, elevated systemic zonulin levels are associated with the depletion of intestinal CD4

Indexed as

chronic immune activationGALTgut-associated lymphatic tissueHIVIFN-αintestinal barriernon-infectious comorbiditieszonulin

Identifiers

PMID39457626
PMCPMC11505231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.